Cypress Capital Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-33,364
| Closed | -$3.31M | – | 247 |
|
|
2019
Q3 | $3.31M | Sell |
33,364
-2,612
| -7% | -$248K | 0.64% | 49 |
|
|
2019
Q2 | $3.33M | Buy |
35,976
+2,826
| +9% | +$268K | 0.66% | 52 |
|
|
2019
Q1 | $3.13M | Sell |
33,150
-103
| -0.3% | -$9.01K | 0.64% | 51 |
|
|
2018
Q4 | $2.13M | Buy |
33,253
+900
| +3% | +$66.4K | 0.49% | 63 |
|
|
2018
Q3 | $2.9M | Sell |
32,353
-1,094
| -3% | -$96.7K | 0.55% | 61 |
|
|
2018
Q2 | $2.66M | Sell |
33,447
-1,750
| -5% | -$145K | 0.55% | 62 |
|
|
2018
Q1 | $3.14M | Sell |
35,197
-6,767
| -16% | -$650K | 0.66% | 56 |
|
|
2017
Q4 | $4.38M | Buy |
41,964
+2,462
| +6% | +$278K | 0.91% | 31 |
|
|
2017
Q3 | $5.76M | Sell |
39,502
-240
| -0.6% | -$32.7K | 1.23% | 24 |
|
|
2017
Q2 | $5.16M | Buy |
39,742
+4,450
| +13% | +$545K | 1.14% | 25 |
|
|
2017
Q1 | $4.39M | Buy |
35,292
+1,602
| +5% | +$192K | 1.03% | 31 |
|
|
2016
Q4 | $3.9M | Sell |
33,690
-2,933
| -8% | -$327K | 0.93% | 35 |
|
|
2016
Q3 | $3.83M | Sell |
36,623
-1,868
| -5% | -$202K | 0.91% | 37 |
|
|
2016
Q2 | $3.8M | Sell |
38,491
-480
| -1% | -$49.7K | 0.89% | 41 |
|
|
2016
Q1 | $3.9M | Sell |
38,971
-200
| -0.5% | -$20.6K | 0.96% | 38 |
|
|
2015
Q4 | $4.69M | Sell |
39,171
-279
| -0.7% | -$32.3K | 1.13% | 33 |
|
|
2015
Q3 | $4.27M | Sell |
39,450
-1,225
| -3% | -$152K | 1.05% | 34 |
|
|
2015
Q2 | $4.71M | Sell |
40,675
-200
| -0.5% | -$22.9K | 1.08% | 32 |
|
|
2015
Q1 | $4.71M | Sell |
40,875
-2,330
| -5% | -$278K | 1.07% | 34 |
|
|
2014
Q4 | $4.83M | Sell |
43,205
-1,337
| -3% | -$141K | 1.12% | 30 |
|
|
2014
Q3 | $4.22M | Sell |
44,542
-4,290
| -9% | -$387K | 1% | 34 |
|
|
2014
Q2 | $4.19M | Sell |
48,832
-5,660
| -10% | -$430K | 0.98% | 33 |
|
|
2014
Q1 | $3.8M | Sell |
54,492
-550
| -1% | -$43.6K | 0.93% | 35 |
|
|
2013
Q4 | $4.65M | Sell |
55,042
-5,100
| -8% | -$404K | 1.14% | 27 |
|
|
2013
Q3 | $4.63M | Sell |
60,142
-1,780
| -3% | -$125K | 1.15% | 30 |
|
|
2013
Q2 | $3.62M | Buy |
+61,922
| New | +$3.73M | 0.76% | 51 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Cypress Capital Group's CELG Position: Q4 2019 in Review
Cypress Capital Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 33,364 shares — an estimated $3.31M sold.
Cypress Capital Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.76M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Cypress Capital Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Cypress Capital Group sold 33,364 Celgene Corp shares in Q4 2019, an estimated $3.31M.
- Cypress Capital Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Cypress Capital Group's Celgene Corp position peaked at $5.76M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Cypress Capital Group's 13F filing for Q4 2019, filed 10 Jan 2020.